Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Price:
282.4 SEK
1.66%
Market Closed
Updated:
Jun 1, 2024
Swedish Orphan Biovitrum AB (publ)
Free Cash Flow
|
Swedish Orphan Biovitrum AB (publ)
Free Cash Flow Peer Comparison
Comparables:
BIOG B
HNSA
BONEX
VITR
BIOA B
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Free Cash Flow
kr2.3B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
32%
|
|
|
Biogaia AB
STO:BIOG B
|
Free Cash Flow
kr377.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Hansa Biopharma AB
STO:HNSA
|
Free Cash Flow
-kr737.7m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Free Cash Flow
-kr227k
|
CAGR 3-Years
86%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Free Cash Flow
kr661m
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
20%
|
|
|
BioArctic AB
STO:BIOA B
|
Free Cash Flow
kr302.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Free Cash Flow?
Free Cash Flow
2.3B
SEK
2.3B
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Free Cash Flow amounts to 2.3B SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
32%
32%
Over the last year, the Free Cash Flow growth was 586%. The average annual Free Cash Flow growth rates for Swedish Orphan Biovitrum AB (publ) have been 41% over the past three years , and 32% over the past ten years .
You don't have any saved screeners yet
